Summary

Triton’s research report suggests that the North America surgical site infection control market is predicted to register growth in terms of revenue at a CAGR of 5.02% during the forecast period 2024-2032.
In North America, the surgical site infection control market is supported by increased awareness of the critical need to prevent infections in healthcare settings. According to the Centers for Disease Control and Prevention (CDC), SSIs are among the most common healthcare-associated infections (HAIs). This has spurred numerous initiatives and regulatory measures to enhance infection control practices. Furthermore, the US Department of Health and Human Services’ National Action Plan to Prevent Health Care-Associated Infections sets ambitious targets for reducing SSIs. Additionally, the implementation of stringent guidelines by bodies like the Association for Professionals in Infection Control and Epidemiology (APIC) has heightened the focus on preventive measures, thereby expanding the market's scope.
The countries analyzed in this region comprise United States and Canada.
The United States spearheads the region’s market, gaining $1938.3 million in 2023
• As per the CDC, around 500,000 surgical site infections are recorded in the US yearly. The rising number of surgical procedures, particularly among an aging population, is driving the demand for advanced SSI control measures.

• The US government, through organizations like the Centers for Medicare & Medicaid Services (CMS), has implemented various policies to reduce SSIs, including financial penalties for hospitals with high infection rates.

• This has led to increased adoption of SSI prevention technologies and practices, such as antimicrobial sutures, advanced wound dressings, and sterilization equipment. Additionally, the FDA has been actively involved in approving new technologies, which is expected to further boost the studied market.
Market Forecast for Canada
The surgical site infection (SSI) control market in Canada is supported by the rising number of surgical procedures and heightened awareness of infection control measures. Surgical site infections are a significant concern in Canadian healthcare, with reports indicating that SSIs frequently lead to complications such as readmissions and revision surgeries, contributing to a substantial financial and resource burden on the healthcare system. Besides, government initiatives and collaborations between public and private entities have played a crucial role in supporting the surgical site infection control market.
The market segmentation comprises procedure, industry vertical, type of infection, and product. The type of infection section includes deep incisional, organ or space, and superficial incisional SSI.
Deep incisional surgical site infections (SSIs) are infections that occur beneath the incision area, involving deeper soft tissues, and can lead to serious complications if not properly managed. These infections typically arise within 30 days post-surgery and can result from contamination during surgery or poor post-operative care. To mitigate the risk of deep incisional SSIs, the use of surgical site infection control products, such as antimicrobial dressings, incision drapes, and infection-resistant sutures, is crucial.
Contender Analysis in the Surgical Site Infection Control Market:
Kimberly-Clark Corporation, an American multinational company, specializes in producing consumer goods, primarily paper-based products. Headquartered in the United States, its operations are organized into three main segments: consumer tissue, personal care, and K-C Professional. The personal care segment focuses on manufacturing and marketing disposable diapers, training pants, swim pants, baby wipes, and products for feminine hygiene and incontinence care. The K-C Professional segment provides wipers, tissue, towels, apparel, soaps, and sanitizers for commercial use. Founded in 1872, Kimberly-Clark has established itself as a leader in its industry, offering a wide range of essential products for consumers and businesses alike.
Other companies thriving in the surgical site infection control market include Johnson & Johnson, Sotera Health LLC, Steris Corporation, and Kimberly-Clark Corporation.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT ANALYSIS ON THE SURGICAL SITE INFECTION CONTROL MARKET
2.1.1. COVID-19 IMPACT
2.2. PORTER’S FIVE FORCES ANALYSIS
2.2.1. THREAT OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTES
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. THREAT OF COMPETITIVE RIVALRY
2.3. KEY MARKET STRATEGIES
2.3.1. PRODUCT LAUNCHES
2.3.2. ACQUISITIONS
2.3.3. BUSINESS DIVESTITURES & EXPANSIONS
2.4. MARKET DRIVERS
2.4.1. ESCALATING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
2.4.2. GROWING GERIATRIC POPULATION
2.4.3. REGULATORY GUIDELINES FOR PREVENTING HOSPITAL-ACQUIRED INFECTION
2.5. MARKET CHALLENGES
2.5.1. INCREASE IN OUTPATIENT TREATMENT UTILIZATION
2.5.2. SURGE IN MEDICAL WASTE DUE TO THE USE OF DISPOSABLE MEDICAL ITEMS
2.5.3. INSUFFICIENT AWARENESS REGARDING HOSPITAL-ACQUIRED INFECTIONS
2.6. MARKET OPPORTUNITIES
2.6.1. GROWTH OF MINIMALLY INVASIVE AND OUTPATIENT SURGICAL PRACTICES
2.6.2. RISE IN SURGICAL PROCEDURE RATES
2.6.3. TECHNOLOGICAL ADVANCEMENTS IN PREVENTING SURGICAL SITE INFECTIONS
2.7. ANALYST PERSPECTIVE
3. NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY PROCEDURE
3.1. LAPAROSCOPY
3.2. ORTHOPEDIC SURGERY
3.3. CARDIOVASCULAR
3.4. OBSTETRICS AND GYNECOLOGY
3.5. WOUND CLOSURE
3.6. PLASTIC & RECONSTRUCTIVE SURGERY
3.7. THORACIC SURGERY
3.8. MICROVASCULAR
3.9. UROLOGY
3.10. NEUROSURGERY
3.11. OTHER PROCEDURES
4. NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY TYPE OF INFECTION
4.1. SUPERFICIAL INCISIONAL SSI
4.2. DEEP INCISIONAL SSI
4.3. ORGAN OR SPACE SSI
5. NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY INDUSTRY VERTICAL
5.1. HOSPITALS
5.2. AMBULATORY SURGICAL CENTERS
6. NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY PRODUCT
6.1. DISINFECTANTS
6.1.1. SKIN DISINFECTANTS
6.1.2. HAND DISINFECTANTS
6.2. MANUAL REPROCESSORS SOLUTIONS
6.3. SURGICAL DRAPES
6.4. SURGICAL GLOVES
6.5. SKIN PREPARATION SOLUTIONS
6.6. SURGICAL IRRIGATION
6.7. SURGICAL SCRUBS
6.8. HAIR CLIPPERS
6.9. MEDICAL NONWOVENS
6.10. OTHER PRODUCTS
7. NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY COUNTRY OUTLOOK
7.1. NORTH AMERICA
7.1.1. COUNTRY ANALYSIS
7.1.1.1. UNITED STATES
7.1.1.1.1. UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.1.1.2. CANADA
7.1.1.2.1. CANADA SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
8. COMPETITIVE LANDSCAPE
8.1. AMERICAN POLYFILM INC
8.1.1. OVERVIEW
8.1.2. PORTFOLIO
8.1.3. KEY STRENGTHS
8.1.4. KEY CHALLENGES
8.2. 3M
8.2.1. OVERVIEW
8.2.2. PORTFOLIO
8.2.3. KEY STRENGTHS
8.2.4. KEY CHALLENGES
8.3. ANSELL LIMITED
8.3.1. OVERVIEW
8.3.2. PORTFOLIO
8.3.3. KEY STRENGTHS
8.3.4. KEY CHALLENGES
8.4. BELIMED LIFE SCIENCE AG
8.4.1. OVERVIEW
8.4.2. PORTFOLIO
8.4.3. KEY STRENGTHS
8.4.4. KEY CHALLENGES
8.5. BECTON, DICKINSON AND COMPANY (BD)
8.5.1. OVERVIEW
8.5.2. PORTFOLIO
8.5.3. KEY STRENGTHS
8.5.4. KEY CHALLENGES
8.6. BIOMERIEUX SA
8.6.1. OVERVIEW
8.6.2. PORTFOLIO
8.6.3. KEY STRENGTHS
8.6.4. KEY CHALLENGES
8.7. GETINGE AB
8.7.1. OVERVIEW
8.7.2. PORTFOLIO
8.7.3. KEY STRENGTHS
8.7.4. KEY CHALLENGES
8.8. GAMA HEALTHCARE
8.8.1. OVERVIEW
8.8.2. PORTFOLIO
8.8.3. KEY STRENGTHS
8.8.4. KEY CHALLENGES
8.9. JOHNSON & JOHNSON
8.9.1. OVERVIEW
8.9.2. PORTFOLIO
8.9.3. KEY STRENGTHS
8.9.4. KEY CHALLENGES
8.10. SOTERA HEALTH LLC
8.10.1. OVERVIEW
8.10.2. PORTFOLIO
8.10.3. KEY STRENGTHS
8.10.4. KEY CHALLENGES
8.11. KIMBERLY-CLARK CORPORATION
8.11.1. OVERVIEW
8.11.2. PORTFOLIO
8.11.3. KEY STRENGTHS
8.11.4. KEY CHALLENGES
8.12. STERIS CORPORATION
8.12.1. OVERVIEW
8.12.2. PORTFOLIO
8.12.3. KEY STRENGTHS
8.12.4. KEY CHALLENGES
8.13. STRYKER CORPORATION
8.13.1. OVERVIEW
8.13.2. PORTFOLIO
8.13.3. KEY STRENGTHS
8.13.4. KEY CHALLENGES
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

LIST OF TABLES
TABLE 1: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 2: LIST OF PRODUCT LAUNCHES
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 5: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 6: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $ MILLION)
TABLE 7: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 8: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 9: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)

LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCES ANALYSIS
FIGURE 2: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2023 & 2032 (IN %)
FIGURE 3: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2024-2032 (IN $ MILLION)
FIGURE 4: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 5: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 6: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 7: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2024-2032 (IN $ MILLION)
FIGURE 8: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 9: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 10: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 11: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY UROLOGY, 2024-2032 (IN $ MILLION)
FIGURE 12: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2024-2032 (IN $ MILLION)
FIGURE 13: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2024-2032 (IN $ MILLION)
FIGURE 14: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2023 & 2032 (IN %)
FIGURE 15: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 16: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 17: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2024-2032 (IN $ MILLION)
FIGURE 18: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2023 & 2032 (IN %)
FIGURE 19: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 20: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 21: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2023 & 2032 (IN %)
FIGURE 22: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 23: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2023 & 2032 (IN %)
FIGURE 24: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 25: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY HAND DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 26: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTIONS, 2024-2032 (IN $ MILLION)
FIGURE 27: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2024-2032 (IN $ MILLION)
FIGURE 28: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2024-2032 (IN $ MILLION)
FIGURE 29: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTIONS, 2024-2032 (IN $ MILLION)
FIGURE 30: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2024-2032 (IN $ MILLION)
FIGURE 31: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2024-2032 (IN $ MILLION)
FIGURE 32: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2024-2032 (IN $ MILLION)
FIGURE 33: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2024-2032 (IN $ MILLION)
FIGURE 34: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)
FIGURE 35: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 36: UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 37: CANADA SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)